par Van Antwerpen, Pierre ;Dufrasne, François ;Lequeux, Mathieu;Zouaoui Boudjeltia, Karim ;Lessgyer, I.;Babar, Sajida ;Moreau, Patrick ;Moguilevsky, Nicole ;Vanhaeverbeek, Michel ;Ducobu, Jean ;Neve, Jean
Référence European journal of pharmacology, 570, 1-3, page (235-243)
Publication Publié, 2007-09
Référence European journal of pharmacology, 570, 1-3, page (235-243)
Publication Publié, 2007-09
Article révisé par les pairs
Titre: |
|
Auteur: | Van Antwerpen, Pierre; Dufrasne, François; Lequeux, Mathieu; Zouaoui Boudjeltia, Karim; Lessgyer, I.; Babar, Sajida; Moreau, Patrick; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Ducobu, Jean; Neve, Jean |
Informations sur la publication: | European journal of pharmacology, 570, 1-3, page (235-243) |
Statut de publication: | Publié, 2007-09 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Chronic inflammatory syndromes |
Compound II | |
Flufenamic acid | |
Human myeloperoxidase | |
LDL | |
Non-steroidal anti-inflammatory drugs | |
MeSH keywords: | Anti-Inflammatory Agents, Non-Steroidal -- metabolism |
Cell Line | |
Chlorine -- metabolism | |
Cholesterol, LDL -- metabolism | |
Endothelial Cells -- metabolism | |
Flufenamic Acid -- metabolism | |
Humans | |
Hydrogen Peroxide -- metabolism | |
Hypochlorous Acid -- metabolism | |
Oxidation-Reduction | |
Peroxidase -- antagonists & inhibitors | |
Peroxidase -- metabolism | |
Recombinant Proteins -- metabolism | |
Note générale: | Journal Article |
Langue: | Anglais |
Identificateurs: | urn:issn:0014-2999 |
info:doi/10.1016/j.ejphar.2007.05.057 | |
info:pii/S0014-2999(07)00658-9 | |
info:scp/34547837573 | |
info:pmid/17610876 |